Should you buy Xylem stock now?
No, the technical signal for Xylem is currently Strong Sell. Xylem trades at $103.53 as of Oct 20, 2026. The technical analysis shows the following: MACD is negative (bearish trend) at -1.290 with rising momentum (signal: -1.825); RSI is at 45.3 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $145.00 points to 40.1% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Xylem stock?
The average analyst price target for Xylem is $145.00. The current price is $103.53, which gives an upside of 40.1%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $130.50 and $159.50.
Is Xylem a dividend stock?
Yes, Xylem is a dividend stock with a dividend yield of 1.61%. The payout ratio is 31.5%, which is considered sustainable.
What is the risk of Xylem stock?
Xylem is rated as a stock in the risk category Balanced. the annual standard deviation is 25.2%, which classifies the stock as Balanced.
Is Xylem overvalued?
No, Xylem is considered undervalued based on the analyst price target (40.1% upside). Xylem has the following valuation ratios: a P/E ratio of 24.8 (moderately to highly valued), a P/S ratio of 2.7, a P/B ratio of 2.4. The analyst price target suggests that the stock is undervalued by 40.1%.
Is Xylem overbought?
No, Xylem is not overbought. RSI is at 45.3 (neutral zone). The technical indicators show: RSI is at 45.3 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 0.5% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Xylem earnings report?
Xylem reports its next earnings on October 27, 2026. The stock currently trades at $103.53. With a P/E ratio of 24.8, the market will be watching closely whether earnings meet expectations.
Is Xylem shorted?
Yes, Xylem is shorted with 5.8% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Xylem stock?
No, insiders are not buying Xylem shares – they are net sellers. Across the last 20 reported transactions, the split is 2 purchases and 18 sales, with a net 12,994,495 $ sold. Active sellers include McShane Geri-Michelle, Harker Victoria D, Toussaint Claudia S and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Xylem a good stock?
Based on our total score, Xylem is rated as a mediocre stock with a total score of 52 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 55/100, Quality: 68/100, Momentum: 34/100. In addition: analysts see 40.1% upside to the price target; a dividend of 1.61%. Whether now is the time to buy is a separate question: the technical signal is Strong Sell. Whether Xylem is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Xylem stock?
The outlook for Xylem based on current data: the average analyst price target is $145.00 (+40.1%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on Oct 27, 2026, which can move the price; the P/E ratio is 24.8 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Xylem stock moving?
Xylem is stable right now. The technical indicators show: the price is close to the 20-day average; short interest is 5.8% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Xylem go?
The average analyst price target for Xylem is $145.00, which corresponds to a potential gain of 40.1% from the current price of $103.53. The stock has traded between $98.58 and $152.14 over the last 52 weeks. The price is 32.0% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Xylem fall?
The stock has traded as low as $98.58 over the last 52 weeks — that is 4.8% below the current price of $103.53. The biggest decline (drawdown) in the same period was 35.2% from high to low. Within a year, the price typically swings about ±25.2% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Xylem do?
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Wa... The company belongs to the Industrials sector, more specifically the Specialty Industrial Machinery industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Xylem as an investment.
Did Xylem raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Xylem. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Xylem making money or losing money?
Yes, Xylem is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 11.2% — which is solid. The operating margin (profit before interest and taxes) is 17.0%. At a P/E ratio of 24.8, you currently pay 24.8 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Xylem go bankrupt?
The bankruptcy risk of Xylem is rated as low. Altman Z2 (a model for assessing financial distress) is 3.46 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 53% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Xylem have a lot of debt?
No, Xylem has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 53%. For the industrials sector, anything below 100% counts as low debt. Industrial companies often sit at 100-200% because of heavy production assets and long order books. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Xylem service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 53.0x, and net debt equals 0.9 years of earnings (EBITDA).
